Parametric model to analyse the survival of gastric cancer in the presence of interval censoring

Tumori

Volumn 96, Issue 3, 2010, Pages 433-437

  Baghestani, Ahmad Reza ^a   Hajizadeh, Ebrahim ^a   Fatemi, Seyed Reza ^b  

^a TARBIAT MODARES UNIVERSITY   (Iran)

^b SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Gastric cancer; Interval censoring; Parametric model

Indexed keywords

ADULT; ADVANCED CANCER; ARTICLE; CANCER GRADING; CANCER MORTALITY; CANCER SIZE; CANCER STAGING; CANCER SURVIVAL; COHORT ANALYSIS; DEATH; DISTANT METASTASIS; FEMALE; HUMAN; LOGISTIC REGRESSION ANALYSIS; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PROGNOSIS; RETROSPECTIVE STUDY; RISK ASSESSMENT; STATISTICAL MODEL; STATISTICAL PARAMETERS; STOMACH CANCER;

EID: 77954978186     PISSN: 03008916     EISSN: None     Source Type: Journal    
DOI: 10.1177/030089161009600309     Document Type: Article

References (21)

1. Cox DR: Regression models and life-table. J Royal Stat Soc B, 34: 187-220, 1972.
2. Lindsey JC: A study of interval censoring in parametric regression models. Lifetime Data Anal, 4: 329-354, 1998.
3. Lawless JF: Parametric models in survival analysis. In: Encyclopedia of Biostatistics, pp 3254-3264, Wiley, New York, 1998.
4. Efron B: The efficiency of Cox's likelihood function for censored data. J Am Stat Assoc, 72: 557-565, 1977.
5. Oakes D: The asymptotic information in censored survival data. Biometrika, 64: 441-448, 1977.
6. Samarasam I, Chandran BS, Sitaram V, Perakath B, Nair A, Mathew G: Palliative gastrectomy in advanced gastric cancer: is it worthwhile? ANZ J Surg, 76: 60-63, 2006.
7. Murray CJ, Lopez AD: Alternate projections of mortality and disability by cause 1999-2020: global burden of disease study. Lancet, 349: 1498-1504, 1997.
8. Young JL Jr, Roffers SD, Ries LAG, Fritz AG, Hurlbut AA (Eds): SEER Summary Staging Manual - 2000: Codes and Coding Instructions. National Cancer Institute, NIH Pub. No. 01,4969, Bethesda, MD, 2001.
9. Akaike H: A new look at the statistical model identification. IEEE Transactions on Automatic Control, 19: 716-723, 1974.
10. Arveux P, Faivre J, Boutron MC, Piard F, Dusserre-Guion L, Monnet E, Hillon P: Prognosis of gastric carcinoma after curative surgery. A population-based study using multivariate crude and relative survival analysis. Dig Dis Sci, 37: 757-763, 1992.
11. Haugstvedt TK, Viste A, Eide GE, Söreide O: Norwegian multicentre study of survival and prognostic factors in patients undergoing curative resection for gastric carcinoma: the Norwegian Stomach Cancer Trial. Br J Surg, 80: 475-478, 1993.
12. Li C, Oh SJ, Kim S, Hyung WJ, Yan M, Zhu ZG, Noh SH: Risk factors of survival and surgical treatment for advanced gastric cancer with large tumor size. J Gastrointest Surg, 13: 881-885, 2009.
13. Shiraishi N, Inomata M, Osawa N, Yasuda K, Adachi Y, Kitano S: Early and late recurrence after gastrectomy for gastric carcinoma: univariate and multivariate analyses. Cancer, 89: 255-261, 2000.
14. Orsenigo E, Carlucci M, Braga M, Tomajer V, Di Palo S, Tamburini A, Di Carlo V, Staudacher C: Prognostic factors of gastric neoplasm: experience with 1,074 cases undergoing surgical treatment at a single center. Suppl Tumori, 4: 86-87, 2005.
15. Costa ML, de Cássia Braga Ribeiro K, Machado MA, Costa AC, Montagnini AL: Prognostic score in gastric cancer: the importance of a conjoint analysis of clinical, pathologic, and therapeutic factors. Ann Surg Oncol, 14: 362-364, 2007.
16. Coburn NG, Swallow CJ, Kiss A, Law C: Significant regional variation in adequacy of lymph node assessment and survival in gastric cancer. Cancer, 107: 2143-2151, 2006.
17. Ries LAG, Eisner MP, Kosary CL, Hankey BF, Miller BA, Clegg L: Cancer Statistics Review: 1973-1989. NIH pub. No. 92-2789 Bethesda, National Cancer Institute, 23: 1-9, 1992.
18. Damhuis RA, Tilanus HW: The influence of age on resection rates and postoperative mortality in 2773 patients with gastric cancer. Eur J Cancer, 31A: 928-931, 1995.
19. Nardi A, Schemper M: Comparing Cox and parametric models in clinical studies. Statist Med, 22: 3597-3610, 2003.
20. Nardi A, Schemper M: New residuals for Cox regression and their application to outlier screening. Biometrics, 55: 523-529, 1999.
21. Moghimi-Dehkordi B, Safaee A, Pourhoseingholi MA, Fatemi R, Tabeie Z, Zali MR: Statistical comparison of survival models for analysis of cancer data. Asian Pac J Cancer Prev, 9: 417-420, 2008.